Orchard Therapeutics
ORTX
#7081
Rank
โ‚ฌ0.35 B
Marketcap
15,81ย โ‚ฌ
Share price
0.00%
Change (1 day)
248.97%
Change (1 year)

Revenue for Orchard Therapeutics (ORTX)

Revenue in 2023 (TTM): โ‚ฌ20.32 Million

According to Orchard Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ20.68 Million. In 2022 the company made a revenue of โ‚ฌ21.12 Million an increase over the revenue in the year 2021 that were of โ‚ฌ1.47 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Orchard Therapeutics from 2019 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚ฌ20.32 M-3.74%
2022 โ‚ฌ21.12 M1327.98%
2021 โ‚ฌ1.47 M-29.9%
2020 โ‚ฌ2.1 M-5.95%
2019 โ‚ฌ2.24 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ0.54 B 2,545.44% Jersey
โ‚ฌ0.74 B 3,493.58%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.06 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ20.68 M 0.00%๐Ÿ‡ฌ๐Ÿ‡ง UK